Overview

A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)

Status:
NOT_YET_RECRUITING

Trial end date:
2027-09-30

Target enrollment:

Participant gender:

Summary

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial on the Treatment of Bronchial Asthma with Budesonide Formoterol Combined with Immune Modulators (Staphylococcus and Neisseria Tablets)

Phase:

PHASE3

Details

Lead Sponsor:

The First Affiliated Hospital with Nanjing Medical University

Treatments:

Adjuvants, Immunologic
Budesonide, Formoterol Fumarate Drug Combination